Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial

NCT04413214 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Oral Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Carrimycin

Sponsor

Shanghai Jiao Tong University School of Medicine